Clinical trial
Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases
NCT02040116 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- August 31, 2014
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.